Genomic characterization and prognostication applied to a Brazilian cohort of patients with myelofibrosis.

International Journal of Hematology
Alexandre NoninoRinaldo Wellerson Pereira

Abstract

Genomic characterization of patients with myeloproliferative neoplasms (MPN) may lead to better diagnostic classification, prognostic assessment, and treatment decisions. These goals are particularly important in myelofibrosis (MF). We performed target Next Generation Sequencing for a panel of 255 genes and Chromosome Microarray Analysis (CMA) in 27 patients with MF. Patients were classified according to genomic findings and we compared the performance of a personalized prognostication system with IPSS, MIPSS70 and MIPSS70 + v2. Twenty-six patients presented mutations: 11.1% had single driver mutations in either JAK2, CALR or MPL; 85.2% had mutations in non-restricted genes (median: 2 per patient). CMA was abnormal in 91.7% of the 24 cases with available data. Copy-Number-Neutral Loss-of-Heterozygosity was the most common finding (66.7%). Del13q was the most frequent copy number variation, and we could define a 2.4 Mb minimally affected region encompassing RB1, SUCLA2 and CLLS2 loci. The largest genomic subgroup consisted of patients with mutations in genes involved with chromatin organization and splicing control (40.7%) and the personalized system showed better concordance and accuracy than the other prognostic systems. Comp...Continue Reading

References

Jun 6, 1998·Cancer Genetics and Cytogenetics·A L JuneauG W Dewald
Apr 27, 2000·The New England Journal of Medicine·A Tefferi
May 31, 2001·British Journal of Haematology·A TefferiG W Dewald
Mar 8, 2002·Experimental Hematology·Robert KralovicsJosef T Prchal
Sep 13, 2011·Nature·Kenichi YoshidaSeishi Ogawa
Jan 4, 2012·Mayo Clinic Proceedings·Ayalew TefferiAnimesh Pardanani
Sep 27, 2012·Hematology/oncology Clinics of North America·Joannah Score, Nicholas C P Cross
Apr 12, 2013·Blood·Elisa RumiUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative
Jul 6, 2014·Blood·Elisa RumiUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Sep 19, 2014·Blood·Francisco Cervantes
Jun 2, 2015·Clinical Lymphoma, Myeloma & Leukemia·Meenakshi MehrotraGary Lu
May 18, 2016·Hematology/oncology and Stem Cell Therapy·David A Sallman, Eric Padron
Jul 13, 2016·Genes & Development·Nicholas J Dyson
Dec 29, 2016·Blood·William Vainchenker, Robert Kralovics
Dec 8, 2017·Blood·Jyoti Nangalia, Anthony R Green
Dec 12, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paola GuglielmelliAyalew Tefferi
Mar 28, 2018·Cytogenetic and Genome Research·Milton Rego de Paula JuniorJuliana Forte Mazzeu
May 1, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ayalew TefferiAlessandro M Vannucchi
Aug 2, 2018·Blood Cancer Journal·Ayalew TefferiAlessandro M Vannucchi
Oct 12, 2018·The New England Journal of Medicine·Jacob GrinfeldPeter J Campbell
Oct 20, 2019·Leukemia·Fabio P S SantosSrdan Verstovsek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.